Aller au contenu principal
Profil bibliographique

Munemasa Ryu

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

136Publications signalées
1122Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Cholangiocarcinoma and Gallbladder Cancer StudiesHepatocellular Carcinoma Treatment and PrognosisPancreatic and Hepatic Oncology ResearchGallbladder and Bile Duct DisordersPediatric Hepatobiliary Diseases and Treatments

Les publications récentes

Accès ouvert 2010 article OpenAlex

The Benchmark Analysis of Gastric, Colorectal and Rectal Cancer Pathways: Toward Establishing Standardized Clinical Pathway in the Cancer Care

Munemasa Ryu, Masaaki Hamano, Akira Nakagawara, Masayuki Shinoda et autres

Most clinical pathways in treating cancers in Japan are based on individual physician's personal experiences rather than on an empirical analysis of clinical data such as benchmark comparison with other hospitals. Therefore, these pathways are far from being standardized. By comparing detailed …

jp (code pays fourni par la source)

9 citations Japanese Journal of Clinical Oncology
2010 conference-abstract OpenAlex

Association between deficient mismatch repair system and efficacy to irinotecan containing first-line chemotherapy in patients with sporadic metastatic colorectal cancer.

J. Kim, Yongzhe Hong, J. Lee, Munemasa Ryu et autres

3579 Background: Colorectal cancer with deficient mismatch repair system (dMMR) has been associated with favorable prognosis in early-stage disease. The influence of dMMR on response to chemotherapy in metastatic colorectal cancer (mCRC) has not been fully defined yet. The aim of our …

1 citation Journal of Clinical Oncology
2010 conference-abstract OpenAlex

Sorafenib for recurrent hepatocellular carcinoma after liver transplantation.

Baek‐Yeol Ryoo, Do Hyun Yoon, Munemasa Ryu, Soobin S. Lee et autres

e14669 Background: Sorafenib is the only drug that has shown a survival benefit in patients with hepatocellular carcinoma (HCC) in randomized phase III trials. The efficacy and safety of sorafenib in the treatment of recurrent HCC after liver transplantation, however, has not …

3 citations Journal of Clinical Oncology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.